RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 76 filers reported holding RECRO PHARMA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $551,000 | +19.0% | 50,000 | 0.0% | 0.01% | +22.2% |
| Q4 2017 | $463,000 | +3.1% | 50,000 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $449,000 | +27.6% | 50,000 | 0.0% | 0.01% | +28.6% |
| Q2 2017 | $352,000 | -19.5% | 50,000 | 0.0% | 0.01% | -22.2% |
| Q1 2017 | $437,000 | +8.4% | 50,000 | 0.0% | 0.01% | +12.5% |
| Q4 2016 | $403,000 | -8.8% | 50,000 | 0.0% | 0.01% | -11.1% |
| Q3 2016 | $442,000 | +11.1% | 50,000 | 0.0% | 0.01% | +12.5% |
| Q2 2016 | $398,000 | +33.1% | 50,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $299,000 | -33.6% | 50,000 | 0.0% | 0.01% | -33.3% |
| Q4 2015 | $450,000 | -25.2% | 50,000 | 0.0% | 0.01% | -25.0% |
| Q3 2015 | $602,000 | -8.2% | 50,000 | -1.6% | 0.02% | -11.1% |
| Q2 2015 | $656,000 | +556.0% | 50,800 | +361.8% | 0.02% | +500.0% |
| Q1 2015 | $100,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
| First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
| AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
| Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
| HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
| Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
| Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
| TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
| ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |